MedPath

Analysis of corneal endothelial dysfunctio

Not Applicable
Conditions
corneal endothelial dysfunction
Registration Number
JPRN-UMIN000046035
Lead Sponsor
Kawasaki Medical School
Brief Summary

The mean logMAR visual acuity was improved at 3, 6, 12, and 18 months after ripasudil administration. LogMAR changes 18 months after administration were 0.181 0.170 in the ripasudil group and were significantly superior (P = 9.5 10-4) to those in the control group (-0.057 0.106).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Active ocular surface disease.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath